CONMED

Yahoo Finance • yesterday

Surgical Equipment & Consumables - Diversified Stocks Q4 Recap: Benchmarking Solventum (NYSE:SOLV)

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including Solventum (NYSE:SOLV) and its peers. The surgical equipment and consumables... Full story

Yahoo Finance • 18 days ago

CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as investors reacted to escalating uncertainty tied to the U.S.-Iran conflict and poli... Full story

Yahoo Finance • 19 days ago

3 Value Stocks with Open Questions

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cent... Full story

Yahoo Finance • 28 days ago

[Latest] Global Surgical Stapling Devices Market Size/Share Worth USD 10.14 Billion by 2035 at a 7.2% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Surgical Stapling Devices Market size & share revenue was valued at approximately USD... Full story

Yahoo Finance • 28 days ago

CONMED cut to Neutral at Piper Sandler on lack of catalysts

[Wall Street New York City] aluxum/E+ via Getty Images Shares of Conmed Corporation (CNMD [https://seekingalpha.com/symbol/CNMD]) fell on Tuesday after Piper Sandler downgraded the stock to Neutral from Overweight, noting a lack of cataly... Full story

Yahoo Finance • 28 days ago

DraftKings, Eli Lilly downgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Morgan Stanley upgraded Lemonade (LMND... Full story

Yahoo Finance • 2 months ago

3 Reasons CNMD is Risky and 1 Stock to Buy Instead

Over the past six months, CONMED’s shares (currently trading at $45.91) have posted a disappointing 15.7% loss, well below the S&P 500’s 7.2% gain. This was partly due to its softer quarterly results and might have investors contemplating... Full story

Yahoo Finance • 4 months ago

Conmed to exit gastroenterology business

US-based Conmed is exiting its gastroenterology business, reflecting the company’s aim to sharpen its focus on higher growth margin business lines as part of a broader portfolio optimisation strategy. The business anticipates that the exi... Full story

Yahoo Finance • 4 months ago

Sector Update: Health Care Stocks Lower Late Afternoon

Health care stocks declined late Friday afternoon, with the NYSE Health Care Index falling 0.3% and PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 4 months ago

3 of Wall Street’s Favorite Stocks We Think Twice About

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about com... Full story

Yahoo Finance • 5 months ago

Conmed signals $150M share repurchase program and narrows 2025 revenue guidance amid strategic portfolio focus

Earnings Call Insights: CONMED Corporation (CNMD) Q3 2025 MANAGEMENT VIEW * Patrick Beyer, President and CEO, reported total sales of approximately $338 million for the quarter, citing "6.7% growth year-over-year as reported and 6.3% g... Full story

Yahoo Finance • 5 months ago

Conmed Q3 25 Earnings Conference Call At 4:30 PM ET

(RTTNews) - Conmed Corp. (CNMD) will host a conference call at 4:30 PM ET on November 5, 2025, to discuss Q3 25 earnings results. To access the live webcast, log on to https://conmed.gcs-web.com/events/event-details/q3-fy25-conmed-earning... Full story

Yahoo Finance • 6 months ago

RSI Alert: CONMED Now Oversold

The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals a... Full story

Yahoo Finance • 6 months ago

Integra LifeSciences, Inspire Medical Systems, Merit Medical Systems, Enovis, and CONMED Shares Are Falling, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. The president's tone and the suggestion of canceling... Full story

Yahoo Finance • 7 months ago

Solventum, CONMED, and STERIS Shares Are Falling, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential tariffs. The probe, condu... Full story

Yahoo Finance • 7 months ago

Implied IJS Analyst Target Price: $122

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied... Full story

Yahoo Finance • 8 months ago

Conmed projects $20M annual supply chain savings as growth drivers accelerate

Earnings Call Insights: CONMED Corporation (CNMD) Q2 2025 MANAGEMENT VIEW * Patrick J. Beyer, President and CEO, highlighted "total sales for the quarter were $342.3 million, which came in slightly above the high end of our guidance ra... Full story

Yahoo Finance • 8 months ago

CONMED Non-GAAP EPS of $1.15 beats by $0.03, revenue of $342.3M beats by $3.88M

* CONMED press release [https://seekingalpha.com/pr/20183596-conmed-corporation-announces-second-quarter-2025-financial-results] (NYSE:CNMD [https://seekingalpha.com/symbol/CNMD]): Q2 Non-GAAP EPS of $1.15 beats by $0.03. * Revenue of... Full story

Yahoo Finance • 9 months ago

Lantheus, ICU Medical, Haemonetics, CONMED, and Astrana Health Shares Plummet, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market sentiment turned negative after the White... Full story

Yahoo Finance • 9 months ago

Martha Aronson to leave CONMED board for CEO role at Merit Medical

LARGO, Fla. - CONMED Corporation (NYSE:CNMD), a medical technology company with a market capitalization of $1.6 billion and annual revenue of $1.32 billion, announced Monday that board member Martha Aronson will resign effective July 7, 20... Full story